Tissue Procurement For Hematolymphoid Conditions

Description

RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.OBJECTIVES: Provide source of patient tissue, blood, and body fluid samples for ongoing diagnostic, prognostic, or immune-monitoring studies. Support and enhance translational, clinical and basic research for Lineberger Comprehensive Cancer Center (LCCC) members (and non-members who have an LCCC member as sponsor and collaborator) with IRB-approved studies. Maintain responsible and appropriate policies and procedures that ensure good patient care and responsible conduct of research. Address medical and legal issues, and protect participant and patient privacy and confidentiality. Provide a responsible and uniform mechanism for the integrated coordination of the hemato-pathologist and

Trial Eligibility

DISEASE CHARACTERISTICS: Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following: Acute myeloid leukemia Acute lymphoblastic leukemia Chronic myelogenous leukemia Chronic lymphoid leukemia Non-Hodgkin lymphoma Hodgkin lymphoma Myelodysplastic syndromes Myeloproliferative disorders Multiple myeloma Waldenstrom macroglobulinemia Aplastic anemia Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital PATIENT CHARACTERISTICS: Not specified PRIOR CONCURRENT THERAPY: Not specified

Study Info

Interventions

Locations Recruiting

Interested in joining this trial?

Our dedicated patient navigators are here to guide you through the validation and enrollment process with ease.